Axsome Therapeutics (AXSM) Tax Provisions (2017 - 2025)
Axsome Therapeutics recorded quarterly Tax Provisions of $460000.0 in Q4 2025, up 146.0% quarter-over-quarter from -$1.0 million in Q2 2025, and up 441.18% year-over-year from $85000.0 in Q4 2024.
Axsome Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $460000.0 for Q4 2025.
- In Q4 2025, Tax Provisions rose 441.18% year-over-year to $460000.0; the TTM figure through Mar 2026 stood at -$540000.0 (down 735.29% YoY), while the FY2025 annual figure was -$500000.0, down 688.24% from the prior year.
- Tax Provisions came in at $460000.0 for Q4 2025 at Axsome Therapeutics, up from -$1.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.6 million in Q1 2023 to a low of -$1.0 million in Q2 2025.
- A 3-year average of $77428.6 and a median of -$325000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 126.15% in 2024 and soared 441.18% in 2025, its largest moves.
- Axsome Therapeutics' Tax Provisions stood at -$325000.0 in 2023, then jumped by 126.15% to $85000.0 in 2024, then jumped by 441.18% to $460000.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $460000.0, -$1.0 million, and $85000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 460,000.00 |
| Jun 30, 2025 | -1.00 Mn |
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2023 | -325,000.00 |
| Sep 30, 2023 | -678,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | 2.60 Mn |
| Sep 30, 2018 | -217,418.00 |
| Sep 30, 2017 | -207,114.00 |